When cancer spreads to the liver from another part of the body, it means tumor cells have traveled through the bloodstream or lymphatic system and established new growths in liver tissue. This is called metastatic liver cancer, or liver metastasis, and it’s different from cancer that starts in the liver itself. The liver remains one of the most common sites for cancer to spread to, and what happens next depends on how much of the liver is involved, where the original cancer started, and how well the liver can still do its job.
Why Cancer Spreads to the Liver So Often
The liver has a unique vulnerability to metastasis because of how blood flows through it. A large vessel called the portal vein drains blood from the entire digestive tract directly into the liver. This essentially creates an escape highway for tumor cells originating in the colon, rectum, pancreas, or stomach. Those cells enter the bloodstream, ride through the portal vein, and get filtered into liver tissue where they can take root.
The right side of the liver receives roughly twice as much blood flow as the left, which is why metastases tend to cluster there more heavily. But cancer from non-digestive organs, like the breast or lungs, can also reach the liver through general blood circulation. The liver filters about 1.5 liters of blood per minute, meaning an enormous volume of blood passes through it constantly, giving circulating tumor cells plenty of opportunity to land and grow.
The most common cancers that spread to the liver are colorectal cancer, pancreatic cancer, and breast cancer. Roughly 20% to 25% of people diagnosed with colorectal cancer will develop liver metastases at some point, and up to a quarter of those cases already have liver involvement at the time of their initial diagnosis.
How It Affects the Liver’s Function
The liver performs hundreds of essential tasks: filtering toxins from blood, producing proteins that help with clotting, processing nutrients, and manufacturing bile for digestion. When tumors grow within the liver, they gradually crowd out healthy tissue and disrupt these processes. The degree of disruption depends on how much of the liver is involved. Small metastases may cause no noticeable problems at all, while widespread disease can push the liver toward failure.
Blood tests often reveal the damage before symptoms appear. Levels of enzymes that signal liver stress (particularly alkaline phosphatase) tend to rise, sometimes dramatically. Bilirubin, the substance the liver processes to keep skin and eyes from yellowing, can build up in the blood. Albumin, a protein the liver produces to maintain fluid balance in the body, may drop. These shifts in liver chemistry are often the first measurable sign that something is wrong.
Symptoms to Recognize
Early liver metastases frequently cause no symptoms, which is why they’re often discovered on imaging scans done for other reasons. As the disease progresses, the most common signs include:
- Pain or discomfort in the upper right abdomen, caused by the liver swelling and stretching the thin capsule that surrounds it
- Unexplained weight loss and loss of appetite
- Jaundice, a yellowish tint to the skin and whites of the eyes that develops when the liver can no longer process bilirubin effectively
- A swollen belly, sometimes from an enlarged liver, sometimes from fluid buildup called ascites
- Fever and fatigue
These symptoms can develop gradually over weeks or appear more suddenly if a tumor blocks a bile duct or a large blood vessel within the liver.
How Liver Metastases Are Found
CT scans are the most commonly used initial tool for detecting liver metastases, but MRI is significantly more sensitive. In a meta-analysis comparing the two for pancreatic cancer patients, MRI detected liver metastases with 83% sensitivity compared to just 45% for CT. Both methods are highly specific, meaning they rarely flag something as cancer when it isn’t, but MRI catches lesions that CT misses, especially small ones.
PET scans, which highlight areas of high metabolic activity, are sometimes used alongside CT to evaluate whether cancer has spread beyond the liver as well. A tissue biopsy, where a small sample is taken from a liver lesion with a needle, can confirm the diagnosis and identify the original cancer type if it’s unknown. Under a microscope, metastatic liver tumors look like the cancer they came from, not like liver cancer. A colorectal metastasis in the liver still looks and behaves like colon cancer.
Treatment Options
Treatment for liver metastases has expanded considerably, and the approach depends on the number, size, and location of tumors, plus the type of original cancer and how healthy the remaining liver tissue is.
Surgery
Surgical removal of liver metastases remains the gold standard when it’s feasible. For colorectal liver metastases, surgery achieves five-year survival rates between 15% and 58%, a wide range that reflects how outcomes vary based on the extent of disease and individual factors. Not everyone is a candidate, though. Surgery typically requires that the tumors be limited enough in number and location that the surgeon can remove them while leaving enough healthy liver behind to function.
Thermal Ablation
For smaller tumors, or for people who aren’t good surgical candidates, ablation uses extreme heat (or sometimes cold) delivered through a needle to destroy tumor cells directly. Research comparing ablation to surgery for colorectal liver metastases has found no significant difference in five-year overall survival between the two approaches, making ablation a reasonable alternative in selected cases.
Radioembolization
This is a minimally invasive outpatient procedure where tiny radioactive beads are threaded through a catheter into the blood vessels feeding a liver tumor. The beads lodge in the tumor’s blood supply and deliver targeted radiation for about two weeks before becoming inactive. Radioembolization can be used as the sole treatment for certain tumors, or it can be used strategically to shrink tumors and make someone a better candidate for surgery. When very high doses are concentrated on a single segment of the liver, this approach can effectively destroy tumors in a technique called radiation segmentectomy.
Systemic Therapy
Chemotherapy, targeted therapy, and immunotherapy travel through the entire body and can attack metastases in the liver along with any cancer elsewhere. The specific drugs depend on the original cancer type. These systemic treatments are often used in combination with localized approaches, or on their own when surgery or ablation isn’t an option.
Managing Symptoms as Disease Progresses
When liver metastases advance, two symptoms in particular can significantly affect daily life: pain and fluid buildup in the abdomen.
Pain from liver metastases usually stems from the liver capsule being stretched as tumors grow. Standard pain relievers like acetaminophen are considered one of the safer options for people with compromised liver function when taken at appropriate doses. For nerve-related pain, medications like gabapentin and pregabalin are often preferred because they aren’t processed by the liver. Lidocaine patches can help with localized pain on the skin or abdominal wall without adding stress to the liver.
Ascites, the accumulation of fluid in the abdominal cavity, can cause significant bloating, discomfort, and difficulty breathing. The fluid can be drained through a procedure called paracentesis, which provides immediate relief but often needs to be repeated as fluid reaccumulates. For people who need frequent drainage, long-term abdominal drains placed at home have shown good results in reducing hospital visits while maintaining comfort. A study known as the REDUCe Study found these drains to be safe, acceptable to patients, and effective at reducing the need for repeated hospital procedures.
What the Outlook Depends On
Survival after a diagnosis of liver metastases varies enormously. The single biggest factor is the original cancer type. Colorectal liver metastases that can be surgically removed carry the most favorable outlook, with five-year survival rates that can reach nearly 60% in the best cases. Metastases from pancreatic cancer, by contrast, tend to carry a much shorter timeline.
Other factors that shape the prognosis include how many tumors are present, whether they’re confined to the liver or have spread to additional organs, how well the liver is still functioning, and how the cancer responds to treatment. A single small metastasis discovered early and treated aggressively is a fundamentally different situation than widespread involvement discovered late.
One important thing to understand: metastatic liver cancer is classified as stage IV disease regardless of the original cancer type. But stage IV is no longer the automatic death sentence it was decades ago. Advances in surgical techniques, ablation technology, and systemic therapies have steadily pushed survival times upward, and for some patients, long-term remission is a realistic possibility.